全球卫生
医疗保健
疾病负担
跨国公司
肾病科
医学
医疗保健系统
肾脏疾病
环境卫生
重症监护医学
发展经济学
经济增长
公共卫生
业务
护理部
财务
经济
内科学
作者
Aminu K. Bello,Ikechi G. Okpechi,Adeera Levin,Feng Ye,Sandrine Damster,Silvia Arruebo,Jo‐Ann Donner,Fergus Caskey,Yeoungjee Cho,M Razeen Davids,Sara N. Davison,Htay Htay,Vivekanand Jha,Rowena Lalji,Charu Malik,Masaomi Nangaku,Emily See,Stephen M. Sozio,Marcello Tonelli,Marina Wainstein,Emily K. Yeung,David W. Johnson
标识
DOI:10.1016/s2214-109x(23)00570-3
摘要
Since 2015, the International Society of Nephrology (ISN) Global Kidney Health Atlas (ISN-GKHA) has spearheaded multinational efforts to understand the status and capacity of countries to provide optimal kidney care, particularly in low-resource settings. In this iteration of the ISN-GKHA, we sought to extend previous findings by assessing availability, accessibility, quality, and affordability of medicines, kidney replacement therapy (KRT), and conservative kidney management (CKM).
科研通智能强力驱动
Strongly Powered by AbleSci AI